2013-02-27 13:36:28 -
MENLO PARK, Calif., February 27, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that Olivia Bloom, Senior Vice President, Finance, and Chief Financial
Officer, will present an overview of the company at 10:40 a.m. Eastern Time on
Wednesday, March 6, at the Cowen and Company 33rd Annual Health Care Conference
A live webcast of the presentation will be available at
wsw.com/webcast/cowen10/gern/. Following the live presentation, the
webcast will be archived and available for replay at the same address for a
period of 30 days.
Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat, in clinical development.
For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Geron Corp. via Thomson Reuters ONE